Robert Kramer, Emergent BioSolutions CEO

Emer­gent scores a DoD award to eval­u­ate its chikun­gun­ya vac­cine in the field

Emer­gent BioSo­lu­tions is look­ing to make progress with its chikun­gun­ya vac­cine and has re­ceived a $10 mil­lion US gov­ern­ment grant to help it along. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.